Dar Al Dawa Development and Investment (AMM:DADI) ROCE %: 9.48% (As of Mar. 2026)


AMM:DADI Dar Al Dawa Development and Investment AMM:DADI
77 GF Score
Price JOD1.14
GF Value JOD1.10
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Dar Al Dawa Development and Investment ROCE %?

Dar Al Dawa Development and Investment AMM:DADI 77 ROCE % is 9.48% as of Mar. 2026. GuruFocus rates AMM:DADI with a GF Score™ of 77/100 and a GF Value™ of JOD1.10 (Fairly Valued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Dar Al Dawa Development and Investment's annualized ROCE % for the quarter that ended in Mar. 2026 was 9.48%.

Dar Al Dawa Development and Investment  (AMM:DADI) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Dar Al Dawa Development and Investment ROCE % Related Terms

Dar Al Dawa Development and Investment ROCE % Historical Data

* Premium members only.

The historical data trend for Dar Al Dawa Development and Investment's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dar Al Dawa Development and Investment ROCE % Chart

Dar Al Dawa Development and Investment Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.97 9.75 13.71 16.55 16.50

Dar Al Dawa Development and Investment Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.24 16.05 7.79 29.73 9.48
AMM:DADI
77GF Score
Dar Al Dawa Development and Investment AMM:DADI
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dar Al Dawa Development and Investment ROCE % Calculation

Dar Al Dawa Development and Investment's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=10.005/( ( (124.161 - 73.707) + (141.302 - 70.463) )/ 2 )
=10.005/( (50.454+70.839)/ 2 )
=10.005/60.6465
=16.50 %

Dar Al Dawa Development and Investment's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=6.82/( ( (141.302 - 70.463) + (142.455 - 69.432) )/ 2 )
=6.82/( ( 70.839 + 73.023 )/ 2 )
=6.82/71.931
=9.48 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 9.48% mean?
Dar Al Dawa Development and Investment (AMM:DADI) has a ROCE % of 9.48% as of Mar. 2026.
Is Dar Al Dawa Development and Investment's ROCE % too high?
Dar Al Dawa Development and Investment's current ROCE % is 9.48%. The Drug Manufacturers industry median ROCE % is 7.03. Dar Al Dawa Development and Investment's value of 9.48% is 34.9% above this industry median. Overall, Dar Al Dawa Development and Investment has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dar Al Dawa Development and Investment's ROCE % compare to ZTS and UTHR?
Dar Al Dawa Development and Investment's ROCE % of 9.48% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.03. Dar Al Dawa Development and Investment's value of 9.48% is 34.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.03, based on 957 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dar Al Dawa Development and Investment's current ROCE % of 9.48% is 34.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dar Al Dawa Development and Investment's current ROCE % is 9.48%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dar Al Dawa Development and Investment stock overvalued right now?
Based on GuruFocus' analysis, Dar Al Dawa Development and Investment (AMM:DADI) is currently considered Fairly Valued. The stock's GF Value™ is JOD1.10, compared to a current price of JOD1.14 — trading 3.6% above its estimated fair value. The current ROCE % is 9.48% and 34.9% above the Drug Manufacturers industry median of 7.03. Dar Al Dawa Development and Investment's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Dar Al Dawa Development and Investment (AMM:DADI), the current ROCE % is 9.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dar Al Dawa Development and Investment (AMM:DADI) Overvalued in 2026?

Based on GuruFocus' analysis, Dar Al Dawa Development and Investment stock appears to be overvalued. The current stock price of JOD1.14 is trading 3.6% above its estimated GF Value™ of JOD1.10. GuruFocus considers Dar Al Dawa Development and Investment to be Fairly Valued.

Key valuation signals for AMM:DADI:

  • ROCE %: 9.48%
  • GF Value™: JOD1.10 vs. price of JOD1.14 (3.6% above fair value)
  • GF Score™: 77/100 with 4 warning signs
  • Industry Position: 34.9% above the Drug Manufacturers median

No single metric tells the full story. See the AMM:DADI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dar Al Dawa Development and Investment Business Description

Address Naour, P.O. Box 9364, Amman, JOR, 11191
Dar Al Dawa Development and Investment is a pharmaceutical company. The main objectives are the production of medical, chemical, and pharmaceutical products, and importing pharmaceutical products. The subsidiaries' main objectives are marketing and distributing the Company's products, producing some specialized medical products, and investment activities. It offers products in the therapeutic areas of anti-infective, cardiovascular, diabetes, dermatology, eye-ear preparations, gastroenterology and metabolism, genitourinary system and sex hormones, musculoskeletal system, nervous system, ophthalmological/otological, and respiratory system, as well as vitamins. The company's geographical segments are Levant and Iraq, Gulf and Yemen, Africa, and Europe and Asia.
77GF Score

Get the complete analysis for AMM:DADI

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

JOD1.14
Price
JOD1.10
GF Value